Biggest News Aggregation in the World
📰 Aldx News

Page 2 - Aldx News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Aldx. Real-time updates on events, politics, business and more.

Aldeyra Therapeutics (NASDAQ:ALDX) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) in a report released on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. Other equities research analysts have also issued reports about the company. Oppenheimer reissued an outperform rating and issued a $14.00 price target on shares of Aldeyra […]
Aldeyra Therapeutics Company Profile Cetera Advisor Networks Raymond James Associates Boothbay Fund Management Ameriprise Financial Inc Aldeyra Therapeutics
Source: wkrb13.com

Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Sees Large Growth in Short Interest

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) was the recipient of a significant growth in short interest in September. As of September 15th, there was short interest totalling 6,450,000 shares, a growth of 5.9% from the August 31st total of 6,090,000 shares. Based on an average trading volume of 646,300 shares, the short-interest ratio […]
Ameritas Investment Partners Inc Tower Research Capital Cubist Systematic Strategies Aldeyra Therapeutics Inc Dorsey Wright Associates Aldeyra Therapeutics Company Profile

Aldeyra Therapeutics (NASDAQ:ALDX) Stock Price Passes Below 50-Day Moving Average of $7.42

Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $7.42 and traded as low as $5.95. Aldeyra Therapeutics shares last traded at $6.15, with a volume of 583,139 shares traded. Analyst Ratings Changes […]
Goldman Sachs Group Inc Knoll Capital Management Blackrock Inc Aldeyra Therapeutics Inc Aldeyra Therapeutics Company Profile Aldeyra Therapeutics

Aldeyra Therapeutics (NASDAQ:ALDX) Cut to "Sell" at StockNews.com

StockNews.com lowered shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a hold rating to a sell rating in a report issued on Sunday. A number of other research firms have also commented on ALDX. Oppenheimer reaffirmed an outperform rating and issued a $14.00 price objective on shares of Aldeyra Therapeutics in a research note […]
Verition Fund Management Knoll Capital Management Blackrock Inc Aldeyra Therapeutics Company Profile Vanguard Group Inc Aldeyra Therapeutics
Source: wkrb13.com

Aldeyra Therapeutics (NASDAQ:ALDX) Downgraded by StockNews.com to "Sell"

StockNews.com cut shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a hold rating to a sell rating in a report released on Sunday morning. Other analysts also recently issued research reports about the company. HC Wainwright reissued a buy rating and issued a $15.00 price objective on shares of Aldeyra Therapeutics in a research […]
York Mellon Corp Vanguard Group Inc Raymond James Associates Jpmorgan Chase Co Aldeyra Therapeutics Free Report

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Aldeyra Therapeutics (NASDAQ:ALDX) Upgraded at StockNews.com

StockNews.com upgraded shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a sell rating to a hold rating in a research report sent to investors on Saturday. Other equities research analysts also recently issued reports about the stock. HC Wainwright reiterated a buy rating and set a $15.00 price objective on shares of Aldeyra Therapeutics […]
Ameritas Investment Partners Inc Dorsey Wright Associates Josephp Lucia Associates Cubist Systematic Strategies Tower Research Capital Aldeyra Therapeutics Company Profile

Aldeyra Therapeutics (NASDAQ:ALDX) Rating Increased to Hold at StockNews.com

Aldeyra Therapeutics (NASDAQ:ALDX – Get Free Report) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a report released on Saturday. ALDX has been the subject of a number of other reports. HC Wainwright reissued a “buy” rating and issued a $15.00 price target on shares of Aldeyra […]
Ameritas Investment Partners Inc Josephp Lucia Associates Tower Research Capital Cubist Systematic Strategies Dorsey Wright Associates Aldeyra Therapeutics

Prosight Management LP Sells 475,262 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX)

Prosight Management LP decreased its holdings in Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Free Report) by 55.3% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 383,447 shares of the biotechnology company’s stock after selling 475,262 shares during the quarter. Aldeyra Therapeutics makes up about […]
Vanguard Group Inc Millennium Management Goldman Sachs Group Inc Eagle Asset Management Inc Aldeyra Therapeutics Inc Verition Fund Management

Aldeyra Therapeutics (NASDAQ:ALDX) Rating Lowered to Sell at StockNews.com

StockNews.com lowered shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a hold rating to a sell rating in a report published on Friday morning. A number of other equities analysts have also recently weighed in on ALDX. Oppenheimer reaffirmed an outperform rating and set a $14.00 price target on shares of Aldeyra Therapeutics in […]
Jpmorgan Chase Co Vanguard Group Inc York Mellon Corp Raymond James Associates Aldeyra Therapeutics Free Report

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science